tirzepatide breastfeeding data If you're on a GLP-1 medication and pregnant or breastfeeding- this one's for you. 👇Here's what the current research says: 💉 Semaglutide- not detected in breast milk 3.5 hours after injection. Reassuring Big news for postpartum moms:

It is not approved for type 1 diabetes or for diabetic ketoacidosis

Dehydration and kidney injury Repeated vomiting or diarrhea can cause volume depletion

Both semaglutide and tirzepatide are once-weekly injections that can treat type 2 diabetes and obesity, when paired with diet and exercise

Read our full list of the best clinics offering Mounjaro

Obesity and obstructive sleep apnoea: exploring the role of tirzepatide Obstructive sleep apnoea is a common, multifactorial condition with obesity as its most important modifiable driver

El tratamiento con Liraglutida (Saxenda) puede ocasionar efectos secundarios frecuentes tales como: Hipoglucemia Nuseas Vmitos Estreimiento / Diarreas El uso adecuado y progresivo de la dosis, guiado por el mdico, evita o revierte casi siempre estos sntomas